Complete tracker for retatrutide's TRIUMPH Phase 3 program — TRIUMPH-1 through TRIUMPH-4 trial details, primary completion timelines, Phase 2 efficacy data (~24.2% weight loss), and estimated FDA approval window (2027–2028).